Rydex Health Care Fund Class H RYHAX

Morningstar Medalist Rating
  • NAV / 1-Day Return $133.88  /  +0.21 %
  • Fund Size $26.8M
  • Adjusted Expense Ratio 1.640%
  • Net Expense Ratio 1.640%
  • Fee Level: Distribution High
  • Share Class Type No Load
  • Morningstar Category Health
  • Equity Style Box (Funds) Mid Blend
  • Minimum Initial Investment $2,500
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 244%

Morningstar’s Analysis RYHAX

Will RYHAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Rydex Health Care H holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RYHAX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 24.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

3.86 849,040
Healthcare

Johnson & Johnson

3.33 731,353
Healthcare

AbbVie Inc

2.83 622,844
Healthcare

Merck & Co Inc

2.59 568,876
Healthcare

UnitedHealth Group Inc

2.29 504,286
Healthcare

Thermo Fisher Scientific Inc

2.18 479,487
Healthcare

Amgen Inc

2.04 448,365
Healthcare

Abbott Laboratories

1.90 417,602
Healthcare

Gilead Sciences Inc

1.77 389,557
Healthcare

Pfizer Inc

1.63 358,624
Healthcare

Sponsor Center